JNK is a critical mediator of insulin resistance, which leads to NASH through dysregulated lipolysis causing excessive transmit of fatty acids to the liver and intracellular accumulation of toxic lipid products that impair insulin signaling and activate inflammatory pathways (163). Here, MAPK8 is linked to metabolic dysfunction-associated steatohepatitis.